Peoples Bank (Kansas)’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$539K Sell
3,710
-85
-2% -$11.7K 0.53% 61
2026
Q2
$488K Hold
3,795
– – 0.47% 64
2026
Q1
$457K Hold
3,795
– – 0.46% 70
2025
Q4
$399K Sell
3,795
-600
-14% -$56.3K 0.4% 72
2025
Q3
$369K Hold
4,395
– – 0.37% 78
2025
Q2
$348K Buy
4,395
+50
+1% +$3.97K 0.23% 96
2025
Q1
$390K Sell
4,345
-200
-4% -$18.7K 0.26% 87
2024
Q4
$452K Sell
4,545
-200
-4% -$20.6K 0.31% 80
2024
Q3
$539K Hold
4,745
– – 0.36% 74
2024
Q2
$587K Hold
4,745
– – 0.46% 57
2024
Q1
$626K Sell
4,745
-921
-16% -$114K 0.49% 57
2023
Q4
$618K Hold
5,666
– – 0.49% 61
2023
Q3
$583K Buy
+5,666
New +$611K 0.5% 59

Other funds holding MRK

Peoples Bank (Kansas)'s MRK Position: Q3 2026 in Review

Peoples Bank (Kansas) reduced its Merck (MRK) stake by 2.2% in Q3 2026, selling an estimated $11.7K and leaving 3,710 shares worth $539K. The position accounts for 0.53% of the portfolio, ranked #61.

Peoples Bank (Kansas) first reported a position in MRK in Q3 2023 and has held it in 13 quarters since. The position peaked at $626K in Q1 2024. 203 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Peoples Bank (Kansas) held 3,710 shares of Merck worth $539K as of Q3 2026.
  • Peoples Bank (Kansas) sold 85 Merck shares in Q3 2026, an estimated $11.7K.
  • Merck made up 0.53% of Peoples Bank (Kansas)'s portfolio in Q3 2026, its #61 holding.
  • Peoples Bank (Kansas) first reported a position in Merck in Q3 2023 and has held it in 13 quarters since.
  • Peoples Bank (Kansas)'s Merck position peaked at $626K in Q1 2024.
  • 203 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Peoples Bank (Kansas)'s 13F filing for Q3 2026, filed 9 Oct 2026.